Physician-Reported Treatment Patterns in Moderate to Severe Chronic Hand Eczema: the RWEAL Multinational Medical Chart Review
Despite being a first-line treatment, 40% of patients with CHE were inadequately treated with or contraindicated to TCS. Over one-quarter of patients progressed to phototherapy or systemic therapy. These results suggest a lack of effective and well-tolerated topical treatment options in CHE. Graphical Abstract available for this article.
Authors
- Alexanne Morillo
- M.N. Crépy (ORCID: https://orcid.org/0000-0002-9824-1034)
- Maria Concetta Fargnoli (ORCID: https://orcid.org/0000-0002-7249-2556)
- Ana Maria Giménez‐Arnau (ORCID: https://orcid.org/0000-0001-5434-7753)
- Jenny M. Norlin (ORCID: https://orcid.org/0000-0001-5402-1884)
- Anthony Bewley (ORCID: https://orcid.org/0000-0003-1195-0290)
- Douglas Maslin (ORCID: https://orcid.org/0000-0002-5440-4436)
- Christian Apfelbacher (ORCID: https://orcid.org/0000-0003-3805-8219)
- Bleuenn Rault (ORCID: https://orcid.org/0000-0003-0423-2899)
- Sonja Molin (ORCID: https://orcid.org/0000-0002-9383-034X)
Institutions
- Universitat Pompeu Fabra (ES)
- Queen's University (CA)
- Barts Health NHS Trust (GB)
- Hotel Dieu Hospital (CA)
- Hôpital Cochin (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôtel-Dieu de Paris (FR)
- San Gallicano Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Leo Pharma (Denmark) (DK)
- Charité - Universitätsmedizin Berlin (DE)
- Otto-von-Guericke-Universität Magdeburg (DE)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1007/s13555-025-01534-8
- Citations
- 3
- Primary Topic
- Contact Dermatitis and Allergies
- Type
- article
- Field-Weighted Citation Impact
- 6.01
Funders
- LEO Pharma